Ballicules.com

Baclofen

LIORESAL

What it isGABA-B receptor agonist; spasticity of spinal origin.

Why this oneIntrathecal delivery makes it uniquely useful for severe spinal spasticity when oral sedation prevents adequate treatment.

What limits itRenal accumulation can cause encephalopathy; abrupt withdrawal can cause rebound spasticity, delirium or seizures — especially from a pump.

FDA-approved for

Off-label

FDA label

FDA dosingPopulationStartTargetMax
Spasticity (e.g., multiple sclerosis, spinal cord conditions)Adult5 mg TID40-80 mg/day divided (titrate)80 mg/day (20 mg QID)

Titration Increase dose every 3 days per titration schedule

Renal Undefined

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy Undefined

Lactation Undefined

NO BOXED WARNINGS

Principal riskAbrupt withdrawal can cause seizures and rebound spasticity

Cost, est. cash$4–$80/month

Generic entry1988

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability2 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Mechanism of action: Baclofen ballicule

Baclofen ballicule: receptor binding, kinetics and half-life diagram

Open Baclofen in the interactive console ↗

Memory aids: mascots and interaction avatars

Baclofen LIORESAL mascot mnemonic cartoon
“Liar’s resale Back fin”
intrathecal baclofen pump
hat resembles GABA-B agonist peg
Baclofen no kinetic interactions avatar
no kinetic interactions

Open Baclofen in the interactive console ↗